Condrosan 400 mg capsulas duras

Leaflet: information for the user

Condrosan 400 mg hard capsules

Chondroitin sulfate

Read this leaflet carefully before starting to take the medicine.themedicine.

-Keep this leaflet, as you may need to read it again.

-Ifyou have any doubts, consult your doctor or pharmacist.

- This medicine has been prescribed for you and should not be given to others, even if they have the same symptoms, as it may harm them.

- If you consider that any of the side effects you are experiencing is severe or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.

1. What is Condrosan and what it is used for

2. Before taking Condrosan

3. How to take Condrosan

4. Possible side effects

5. Storage of Condrosan

6. Additional information

Condrosan is presented in the form of hard capsules for oral administration, available in

packs of 60 capsules. It belongs to the group of other nonsteroidal anti-inflammatory and

antirheumatic agents.

Condrosan is indicated for the symptomatic treatment of osteoarthritis.

Do not take Condrosan

- If you are hypersensitive to chondroitin sulfate or to any of the other components of Condrosan.

Condrosan

Be especially careful with Condrosan

- If you have a severe kidney, liver, or heart disease. Consult your doctor.

doctor.

Use of other medications

Inform your doctor or pharmacist if you are using or have recently used other medications, including those purchased without a prescription.

medications, including those purchased without a prescription.

The administration of Condrosan, at very high doses above the recommended, along with some antiplatelet medication to prevent thrombosis, such as acetylsalicylic acid, dipiridamol, clopidrogel, ditazol, triflusal, and ticlopidina, could slightly increase the effect of the aforementioned medications.

medications.

Taking Condrosan with food and beverages

You can take Condrosan before, during, or after meals. However, if you often experience stomach discomfort when taking medications, it is recommended to take Condrosan after meals.

Condrosan after meals.

Pregnancy and breastfeeding

Do not take Condrosan if you are pregnant, as there is not enough data on its use in pregnant women.

Condrosan if you are pregnant.

The active principles of Condrosan are unknown to pass into breast milk. Therefore, do not take Condrosan if you are breastfeeding, as there is not enough data on the effect it may have on your baby's health.

Condrosan if you are breastfeeding.

Consult your doctor or pharmacist before using any medication.

Driving and using machines

It is not expected that Condrosan will affect your ability to drive vehicles and use machines.

Follow exactly the administration instructions for Condrosan as indicated by your doctor.

Consult your doctor or pharmacist if you have any doubts.

Adults and Seniors

The usual dose is 2 capsules (total daily dose: 800 mg) per day, preferably in a single

administration (2 capsules at once) for at least 3 months. However, and whenever the doctor

considers it appropriate, treatment may be initiated with a dose of 1,200 mg (3 capsules per day,

in a single administration or in 2 administrations) for the first 4 or 6 weeks, followed by 800 mg

(2 capsules per day, preferably in a single administration) until the administration period of at

least 3 months is completed.

Condrosan will be administered for at least 3 months after which a period of rest of 2 months may

be performed, given the residual effect of the product, to subsequently restart treatment following

the same cycle.

The capsules should be taken without chewing. They can be taken before, during or after meals,

with a sufficient amount of liquid.

Children and Adolescents under 18 years

Condrosan is not recommended for use in children and adolescents under 18 years, due to the

absence of data on safety and efficacy.

If you take more Condrosan than you should

If you have taken more Condrosan than you should, it is likely that you will not experience any

symptoms. However, you should inform your doctor or pharmacist.

If you forgot to take Condrosan

Do not take a double dose to compensate for the missed doses.

If you interrupt the treatment with Condrosan

Symptoms may reappear.

If you have any other doubts about the use of this product, ask your doctor or pharmacist..

Like all medications, Condrosan may cause adverse effects, although not all individuals will experience them.

On rare occasions (between 1 and 10 of every 10,000 patients) nausea and/or gastrointestinal disturbances have been described, which generally do not require suspension of treatment.

In very rare occasions (in less than 1 of every 10,000 patients) some cases of edema and/or water retention have been described.

In very rare occasions (in less than 1 of every 10,000 patients) some allergic reactions have been reported.

If you consider any of the adverse effects you are experiencing to be severe or if you notice any adverse effect not mentioned in this prospectus, inform your doctor or pharmacist.

.

Store in the original packaging to protect it from moisture.

Keep out of the reach and sight of children.

Do not use Condrosan after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.

Medicines should not be disposed of through drains or in the trash.Deposit the packaging and medicines you no longer need at the SIGRE collection point at the pharmacy.If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.

Composition of Condrosan

- The active ingredient is chondroitin sulfate 400 mg.

- The other component is magnesium stearate. Composition of the capsule: gelatin, titanium dioxide, quinoline yellow (E-104), indigotin (E-132).

Appearance of the Product and Contents of the Package

Condrosan is presented in the form of hard gelatin capsules.

Condrosan is packaged in a cardboard box containing 60 capsules in blisters.

Holder of the Marketing Authorization and Responsible for Manufacturing

Holder of the Marketing Authorization:

LABORATORIO REIG JOFRE, S.A.

Gran Capitán, 10

08970 Sant Joan Despí (Barcelona)Spain.

Responsible for Manufacturing:

NOUCOR HEALTH., S.A.

Avda. Camí Reial, 51-57

08184 Palau-solità i Plegamans (Barcelona) - Spain

Date of the Last Review of this Leaflet:May 2019

The detailed information of this medication is available on the website of the Spanish Agency of Medicines:http://www.aemps.gob.es